How is CDKL5 diagnosed?

CDKL5 deficiency disorder (CDD) is diagnosed primarily through clinical observation of early-onset seizures followed by definitive molecular genetic testing to identify a pathogenic variant in the CDKL5 gene. Because symptoms often mimic other epilepsy syndromes, a formal diagnosis typically requires confirmation via a blood-based genetic panel or whole-exome sequencing performed by a clinical geneticist or pediatric neurologist.

How is CDKL5 deficiency disorder diagnosed?

The diagnostic process for CDKL5 deficiency disorder usually begins with a clinical evaluation of a child presenting with severe, drug-resistant epilepsy that begins within the first few months of life. Because the clinical features—such as developmental delay, hypotonia, and cortical visual impairment—overlap with many other conditions, doctors use specific testing to confirm the diagnosis:

• Genetic Testing: This is the gold standard. A chromosomal microarray or a targeted epilepsy gene panel, including the CDKL5 gene, is used to identify the mutation.


• Clinical Examination: Specialists look for the hallmark pattern of early-onset seizures, often described as "staring spells" or tonic-clonic activity.


• EEG (Electroencephalogram): While not specific to CDKL5, an EEG is essential to characterize the seizure patterns and differentiate them from other infantile epilepsies.

Why is there often a delay in diagnosis?

Many families in the DiseaseMaps.org community, where 71 individuals with CDKL5 have shared their journeys, report a frustrating "diagnostic odyssey." Patients are frequently misdiagnosed with West syndrome, Lennox-Gastaut syndrome, or Rett syndrome before genetic testing reveals the true cause. This delay occurs because CDKL5 deficiency disorder is a rare neurodevelopmental condition, and general practitioners may not encounter it frequently enough to recognize the subtle early signs.

Which specialists should I consult?

If you suspect CDKL5 deficiency disorder, it is vital to consult a pediatric neurologist or a clinical geneticist. These specialists are best equipped to interpret complex genetic reports and coordinate the multidisciplinary care required for managing the condition. Do not hesitate to seek a second opinion at a specialized epilepsy center if your current medical team is unfamiliar with the nuances of CDKL5.

Next steps

• Request a referral to a clinical geneticist to discuss comprehensive genetic testing.


• Connect with the 71 members of the DiseaseMaps.org CDKL5 community to share experiences and local resource recommendations.


• Contact the International Foundation for CDKL5 Research (IFCR) for clinical trial information and educational materials.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): CDKL5 deficiency disorder.


• Orphanet: CDKL5 deficiency disorder (ORPHA:247657).


• OMIM (Online Mendelian Inheritance in Man): CDKL5 deficiency disorder (#300672).


• International Foundation for CDKL5 Research (IFCR).